LivaNova (NASDAQ and LSE: LIVA) exists at the intersection of advancing technology and transforming lives for people impacted by cardiopulmonary diseases, cardiac rhythm disorders, and the management of refractory epilepsy and treatment-resistant depression. At LivaNova, we believe that partnership leads to progress. That’s why we brought Sorin and Cyberonics together on October 19, 2015 to create LivaNova, a premier global medical technology company.
With a presence in more than 100 countries, LivaNova operates as three business units that develop, manufacture, and market medical technologies for Cardiac Rhythm Management, Cardiac Surgery, and Neuromodulation, with operating headquarters in Clamart, France, Mirandola, Italy, and Houston, Texas, United States, respectively.
United in passion, focus, and commitment, we develop and deliver innovative solutions today for better health tomorrow. Day by day. Life by life. At LivaNova, we deliver health innovation that matters.
Specialties: Medical Technology and Device Innovation for the treatment of cardiopulmonary diseases, cardiac rhythm disorders, and the management of refractory epilepsy and treatment-resistant depression. – meno